surmount-1 tirzepatide weight loss non-diabetic SURPASS to SURMOUNT: The Trials To Know Tirzepatide for maintenance of bodyweight

Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial

Verzehrempfehlung nicht berschreiten

Providers now prescribe GLP-1 medications for type 2 diabetes and weight management due to their significant impact on reducing excess body weight

We find that patients benefit from at least a 12-month comprehensive weight-loss program to establish the proper habits to sustain long-term weight loss If you are not a good candidate for GLP-1 agonists, our physicians will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools that we use as a part of our weight loss program in Fort Worth, Texas